These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12401244)

  • 41. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial.
    Van't Hof AW; Ten Berg J; Heestermans T; Dill T; Funck RC; van Werkum W; Dambrink JH; Suryapranata H; van Houwelingen G; Ottervanger JP; Stella P; Giannitsis E; Hamm C;
    Lancet; 2008 Aug; 372(9638):537-46. PubMed ID: 18707985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Magnesium sulphate for treatment of severe tetanus: a randomised controlled trial.
    Thwaites CL; Yen LM; Loan HT; Thuy TT; Thwaites GE; Stepniewska K; Soni N; White NJ; Farrar JJ
    Lancet; 2006 Oct; 368(9545):1436-43. PubMed ID: 17055945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment.
    Oldgren J; Wallentin L; Afzal R; Bassand JP; Budaj A; Chrolavicius S; Fox KA; Granger CB; Mehta SR; Pais P; Peters RJ; Xavier D; Zhu J; Yusuf S;
    Eur Heart J; 2008 Feb; 29(3):315-23. PubMed ID: 18084015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intracoronary versus intravenous bolus abciximab administration in patients undergoing primary percutaneous coronary intervention with acute ST-elevation myocardial infarction: a pooled analysis of individual patient data from five randomised controlled trials.
    Piccolo R; Eitel I; Iversen AZ; Gu YL; Dominguez-Rodriguez A; de Smet BJ; Mahmoud KD; Abreu-Gonzalez P; Thiele H; Piscione F
    EuroIntervention; 2014 Jan; 9(9):1110-20. PubMed ID: 24457282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of magnesium infusion on thrombolytic and non-thrombolytic treated patients with acute myocardial infarction.
    Thögersen AM; Johnson O; Wester PO
    Int J Cardiol; 1993 Apr; 39(1):13-22. PubMed ID: 7691765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trial.
    Roolvink V; Rasoul S; Ottervanger JP; Dambrink JH; Lipsic E; van der Horst IC; de Smet B; Kedhi E; Marcel Gosselink AT; Piek JJ; Sanchez-Brunete V; Ibanez B; Fuster V; Van't Hof AW;
    Am Heart J; 2014 Nov; 168(5):661-6. PubMed ID: 25440793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous magnesium sulfate treatment for acute asthma in the emergency department: a systematic review of the literature.
    Rowe BH; Bretzlaff JA; Bourdon C; Bota GW; Camargo CA
    Ann Emerg Med; 2000 Sep; 36(3):181-90. PubMed ID: 10969218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous magnesium sulphate in the management of moderate to severe acute asthmatic children nonresponding to conventional therapy.
    Gürkan F; Haspolat K; Boşnak M; Dikici B; Derman O; Ece A
    Eur J Emerg Med; 1999 Sep; 6(3):201-5. PubMed ID: 10622383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of nebulised magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in adults: a randomised double-blind placebo-controlled trial.
    Edwards L; Shirtcliffe P; Wadsworth K; Healy B; Jefferies S; Weatherall M; Beasley R;
    Thorax; 2013 Apr; 68(4):338-43. PubMed ID: 23299960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff.
    Thel MC; Armstrong AL; McNulty SE; Califf RM; O'Connor CM
    Lancet; 1997 Nov; 350(9087):1272-6. PubMed ID: 9357406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI registry and randomized trial.
    Cohen M; Gensini GF; Maritz F; Gurfinkel EP; Huber K; Timerman A; Krzeminska-Pakula M; Santopinto J; Hecquet C; Vittori L;
    Circulation; 2003 Oct; 108(16 Suppl 1):III14-21. PubMed ID: 14605015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction.
    French JK; Edmond JJ; Gao W; White HD; Eikelboom JW
    Am J Cardiovasc Drugs; 2004; 4(2):107-15. PubMed ID: 15049722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.
    Chen ZM; Pan HC; Chen YP; Peto R; Collins R; Jiang LX; Xie JX; Liu LS;
    Lancet; 2005 Nov; 366(9497):1622-32. PubMed ID: 16271643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial.
    Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators
    Lancet; 2006 Feb; 367(9510):569-78. PubMed ID: 16488800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy.
    Shechter M; Hod H; Chouraqui P; Kaplinsky E; Rabinowitz B
    Am J Cardiol; 1995 Feb; 75(5):321-3. PubMed ID: 7856520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trial.
    Silverman RA; Osborn H; Runge J; Gallagher EJ; Chiang W; Feldman J; Gaeta T; Freeman K; Levin B; Mancherje N; Scharf S;
    Chest; 2002 Aug; 122(2):489-97. PubMed ID: 12171821
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of intravenous administration of SO4Mg in the acute phase of myocardial infarct].
    Pereira D; Pereira TG; Rabaçal C; Carvalho E; Linder J; Afonso JS; Pereira JN; Halpern MJ; Fernandes JS
    Rev Port Cardiol; 1990 Mar; 9(3):205-10. PubMed ID: 2390281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial.
    Wong GK; Poon WS; Chan MT; Boet R; Gin T; Ng SC; Zee BC;
    Stroke; 2010 May; 41(5):921-6. PubMed ID: 20378868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysis.
    Venetsanos D; Sederholm Lawesson S; Alfredsson J; Janzon M; Cequier A; Chettibi M; Goodman SG; Van't Hof AW; Montalescot G; Swahn E
    BMJ Open; 2017 Sep; 7(9):e015241. PubMed ID: 28939567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is there a place for magnesium in the treatment of acute myocardial infarction?
    Seelig MS; Elin RJ
    Am Heart J; 1996 Aug; 132(2 Pt 2 Su):471-7; discussion 496-502. PubMed ID: 8694006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.